The Cystic Fibrosis Program for Individualized Therapy is used to facilitate therapy discovery for people suffering from rare CF-causing mutations.
It has been an exciting year for Canadians impacted by cystic fibrosis (CF), particularly now with Trikafta being funded in all jurisdictions in..